<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on September 20, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/ct2/show/NCT04474678</url>
  </required_header>
  <id_info>
    <org_study_id>1564/2017</org_study_id>
    <nct_id>NCT04474678</nct_id>
  </id_info>
  <brief_title>Quality Improvement Project - &quot;My Logbook! - I Know my Way Around!&quot;; (&quot;Mein Logbuch - Ich Kenne Mich Aus!&quot;)</brief_title>
  <official_title>A Quality Improvement Project to Implement Psychosocial Care Standards in Clinical Practice in Pediatric Oncology &quot;My Logbook! - I Know my Way Around!&quot; (&quot;Mein Logbuch - Ich Kenne Mich Aus!&quot;) Development and Evaluation of a Consensus and Evidence Based Psychosocial Therapy Tool in a Preliminary Psychosocial Study on Therapy Optimization.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of Vienna</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>St. Anna Kinderspital, Austria</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Charite University, Berlin, Germany</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Cnopfsche Kinderklinik, Nürnberg</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Kepler University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospital, Saarland</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hannover Medical School</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Krankenhaus Bozen</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Goethe University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Universitätsklinikum Hamburg-Eppendorf</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Universitätsklinikum Leipzig</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospital Muenster</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospital Tuebingen</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Salzburger Landeskliniken</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Leuwaldhof St.Veit (Kinder- und Jugendreha)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospital, Essen</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Medical University of Graz</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospital Erlangen</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Wuerzburg University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Klinik Bad Oexen, Germany</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Universitätsklinikum Köln</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospital Schleswig-Holstein</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospital Carl Gustav Carus</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Universitätsmedizin Mannheim</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospital Regensburg</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Luca-Dethlefsen-Hilfe e.V.</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Insel Gruppe AG, University Hospital Bern</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Staedtisches Klinikum Karlsruhe</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Medical University of Vienna</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this study, the main goal is to implement and evaluate a novel, evidence-based&#xD;
      psycho-educative program for children in oncological care. Patients are provided with&#xD;
      booklets tailored to each specific stage of their treatment. Among other factors, children's&#xD;
      emotional well-being is evaluated as well as feasibility. The study is carried out at&#xD;
      multiple sites across Austria, Germany and Italy/South Tirol.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      It is well documented that the prevalence of mental disorders in childhood cancer survivors&#xD;
      is twice to quadruple compared to healthy controls. Effects range from impaired emotional&#xD;
      balance, fear of recidivisms, helplessness, depression to post traumatic stress disorder.&#xD;
&#xD;
      As a basis for interventions to preventively address these issues and moreover, to achieve&#xD;
      defined psychosocial goals in the field of paediatric oncology, guidelines and standards&#xD;
      systematically describe stressors and resources in particularly challenging situations.&#xD;
      Nevertheless, despite these guidelines, actual care is quite heterogenous due to differences&#xD;
      in setting, provision and profession. Studies show that integrated models of psychosocial&#xD;
      care yield better outcomes. Integrated care systems can enhance patient satisfaction,&#xD;
      increase perceived quality of care, and enable access to services and reduce service costs.&#xD;
      Highly complex, system-wide interventions such as models of integrated care represent&#xD;
      considerable challenges for operationalisation of relevant factors and evaluation of whole&#xD;
      processes compared to single interventions (e.g. relaxation techniques). Quality improvement&#xD;
      (QI) is an iterative process designed to make controlled changes within the health care&#xD;
      delivery system to provide patients with high-quality care that meets both their expectations&#xD;
      and needs. In terms of quality assurance, this QI Project aims to operationalize&#xD;
      recommendations of the S3 guideline for psychosocial care which results in a combined&#xD;
      process- and patient-oriented intervention and evaluation tool - bridging the gap between&#xD;
      standards/evidence and clinical practice.&#xD;
&#xD;
      The &quot;Onco-Mini-Version&quot; of &quot;My Logbook - I know my way around&quot; already comprises a&#xD;
      Starter-Kit and 8 booklets, which cover at least one main issue of every treatment phase:&#xD;
      initial contact, medical assessment (MRI), supportive therapy (chemotherapy, radio therapy),&#xD;
      rehabilitation and after-care. All interventions are carried out by a clinical psychologist&#xD;
      or psychosocial staff specialized in pediatric psychooncology and are understood as part of&#xD;
      an integrated care system. Every booklet provides practical materials with enhanced&#xD;
      stimulating elements to encourage the child to explore actively. The booklets are structured&#xD;
      in two face-to-face sessions covering psychoeducational, activity &amp; practice and reflective&#xD;
      aspects.&#xD;
&#xD;
      The core of this QI project is a multilevel and interdisciplinary approach characterized by&#xD;
      iterative processes. PDSA (Plan, Do, Study, Act) cycles were applied in all steps of&#xD;
      conceptualization and implementation of this project. It aims to systematically improve&#xD;
      psychosocial care of pediatric cancer patients through being implemented in a large number of&#xD;
      hospitals in the German-speaking world. The proposed multicenter pilot phase promotes&#xD;
      emotional well-being and level of information of the child during treatment through transfer&#xD;
      of knowledge and coping skills. Moreover, it addresses feasibility of the tool but also the&#xD;
      impact of medical procedures on feasibility. In the long term, the program is intended to&#xD;
      help attenuate psychological late effects of oncological conditions and their treatments.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 7, 2020</start_date>
  <completion_date type="Anticipated">December 2023</completion_date>
  <primary_completion_date type="Anticipated">December 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Emotional well-being, T1</measure>
    <time_frame>Based on the medical therapy protocol, after medical consultation, prior to first session of the special issue (booklet) - through study completion or end of medical treatment, an average of 1 year</time_frame>
    <description>Patients' emotional well-being is evaluated using a visual array of emotional displays. Patients can choose three emotions that describe their current situation best. For analysis, emotions are categorized into positive, neutral, and negative emotions. Emotional well-being is evaluated longitudinally over multiple points of time. The diagnostic tool was developed in-house, publication is pending.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Emotional well-being, T2</measure>
    <time_frame>Post to first session of the special issue (booklet) - through study completion or end of medical treatment, an average of 1 year</time_frame>
    <description>Patients' emotional well-being is evaluated using a visual array of emotional displays. Patients can choose three emotions that describe their current situation best. For analysis, emotions are categorized into positive, neutral, and negative emotions. Emotional well-being is evaluated longitudinally over multiple points of time. The diagnostic tool was developed in-house, publication is pending.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Emotional well-being, T3</measure>
    <time_frame>During, but before completion of treatment; prior to second session of the special issue (booklet) - through study completion or end of medical treatment, an average of 1 year</time_frame>
    <description>Patients' emotional well-being is evaluated using a visual array of emotional displays. Patients can choose three emotions that describe their current situation best. For analysis, emotions are categorized into positive, neutral, and negative emotions. Emotional well-being is evaluated longitudinally over multiple points of time. The diagnostic tool was developed in-house, publication is pending.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Emotional well-being, T4</measure>
    <time_frame>During, post to second session of the special issue (booklet) - through study completion or end of medical treatment, an average of 1 year</time_frame>
    <description>Patients' emotional well-being is evaluated using a visual array of emotional displays. Patients can choose three emotions that describe their current situation best. For analysis, emotions are categorized into positive, neutral, and negative emotions. Emotional well-being is evaluated longitudinally over multiple points of time. The diagnostic tool was developed in-house, publication is pending.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Emotional well-being, T5</measure>
    <time_frame>During, but before completion of treatment - through study completion or end of medical treatment, an average of 1 year</time_frame>
    <description>Patients' emotional well-being is evaluated using a visual array of emotional displays. Patients can choose three emotions that describe their current situation best. For analysis, emotions are categorized into positive, neutral, and negative emotions. Emotional well-being is evaluated longitudinally over multiple points of time. The diagnostic tool was developed in-house, publication is pending.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Knowledgeability, T1</measure>
    <time_frame>Based on the medical therapy protocol, after medical consultation, prior to first session of the special issue (booklet) - through study completion or end of medical treatment, an average of 1 year</time_frame>
    <description>Patients are asked to rate their own knowledgeability regarding treatment, illness and hospital environment on a five-point scale ranging from &quot;beginner&quot; to &quot;expert&quot;. Knowledgeability is evaluated longitudinally over multiple points of time. The diagnostic tool was developed in-house.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Knowledgeability, T2</measure>
    <time_frame>Post to first session of the special issue (booklet) - through study completion or end of medical treatment, an average of 1 year</time_frame>
    <description>Patients are asked to rate their own knowledgeability regarding treatment, illness and hospital environment on a five-point scale ranging from &quot;beginner&quot; to &quot;expert&quot;. Knowledgeability is evaluated longitudinally over multiple points of time. The diagnostic tool was developed in-house.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Knowledgeability, T3</measure>
    <time_frame>During, but before completion of treatment; prior to second session of the special issue (booklet) - through study completion or end of medical treatment, an average of 1 year</time_frame>
    <description>Patients are asked to rate their own knowledgeability regarding treatment, illness and hospital environment on a five-point scale ranging from &quot;beginner&quot; to &quot;expert&quot;. Knowledgeability is evaluated longitudinally over multiple points of time. The diagnostic tool was developed in-house.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Knowledgeability, T4</measure>
    <time_frame>During, post to second session of the special issue (booklet) - through study completion or end of medical treatment, an average of 1 year</time_frame>
    <description>Patients are asked to rate their own knowledgeability regarding treatment, illness and hospital environment on a five-point scale ranging from &quot;beginner&quot; to &quot;expert&quot;. Knowledgeability is evaluated longitudinally over multiple points of time. The diagnostic tool was developed in-house.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Knowledgeability, T5</measure>
    <time_frame>During, but before completion of treatment - through study completion or end of medical treatment, an average of 1 year</time_frame>
    <description>Patients are asked to rate their own knowledgeability regarding treatment, illness and hospital environment on a five-point scale ranging from &quot;beginner&quot; to &quot;expert&quot;. Knowledgeability is evaluated longitudinally over multiple points of time. The diagnostic tool was developed in-house.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Feasibility of program</measure>
    <time_frame>Feasibility of program is evaluated following the second session which on average takes place one to six months after start of the treatment of the special issue (booklet). - through study completion or end of medical treatment, an average of 1 year</time_frame>
    <description>Rating of feasibility of the program by medical staff</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Intelligence test</measure>
    <time_frame>During the first two months from diagnosis or start of psychosocial treatment - up to three Months</time_frame>
    <description>Patients are administered a standardized intelligence test, dependent on their age, e.g.&#xD;
Wechsler Intelligence Scale for Children IV WISC-IV, Petermann &amp; Petermann, 2014 or other comparable methods due to clinical standards</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Strengths and Difficulties Questionnaire (SDQ; Goodman, 1999)</measure>
    <time_frame>During the first two months from diagnosis or start of psychosocial treatment - up to three Months</time_frame>
    <description>The Strengths and Difficulties Questionnaire (SDQ) is a brief behavioural screening questionnaire about 3-16 year olds.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>KINDLR (Ravens-Sieberer &amp; Bullinger, 2000)</measure>
    <time_frame>During the first two months from diagnosis or start of psychosocial treatment - up to three Months</time_frame>
    <description>The KINDLR is a standardized questionnaire for the assessment of quality of life in children and adolescents.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Questionnaire on Health Competence in Children and Adolescents, (Weiler, Fohn, Pletschko, Schwarzinger, &amp; Leiss, 2017)</measure>
    <time_frame>During the first two months from diagnosis or start of psychosocial treatment - up to three Months</time_frame>
    <description>Questionnaire for the assessment of health competence in children and adolescents</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Medical information</measure>
    <time_frame>Within the first week of treatment - up to three Months</time_frame>
    <description>Diagnosis, date of diagnosis, pre-existing conditions, secondary conditions, form of treatment/therapy, psychiatric diagnoses, neurological status</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Demographic data</measure>
    <time_frame>During the first two months from diagnosis or start of psychosocial treatment - up to three Months</time_frame>
    <description>Age of patient, sex, parents' education, parents' profession, school form, mother language of patient</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">128</enrollment>
  <condition>Brain Tumor</condition>
  <condition>Neurofibromatoses</condition>
  <condition>Sarcoma</condition>
  <condition>Leukemia</condition>
  <condition>Hematologic Diseases</condition>
  <condition>Neuroblastoma</condition>
  <arm_group>
    <arm_group_label>All Patients</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Since this is a single-group study, all patients are within the same arm</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>&quot;My Logbook! - I know my way around!&quot;</intervention_name>
    <description>Special issues/booklets of &quot;My Logbook - I know my way around!&quot; - Every booklet is based on evidence-based interventions. It illustrates psychosocial and interdisciplinary processes in a standardized way, resulting in a practical guide (&quot;My Logbook&quot;) to accompany the child throughout all stages of oncological treatment.</description>
    <arm_group_label>All Patients</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria experimental group:&#xD;
&#xD;
          -  currently or formerly treated for oncological condition&#xD;
&#xD;
          -  children/families at standard risk (Pediatric Psychosocial Preventative Health Model&#xD;
             (PPPHM))&#xD;
&#xD;
          -  at least average cognitive abilities (as measured via intelligence test)&#xD;
&#xD;
        Inclusion Criteria control group:&#xD;
&#xD;
          -  currently or formerly treated for oncological condition&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  non-German speaking&#xD;
&#xD;
          -  Major vision impairments&#xD;
&#xD;
          -  Major auditive impairments&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Years</minimum_age>
    <maximum_age>14 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Liesa Weiler-Wichtl, Dr.</last_name>
    <phone>+43140400</phone>
    <phone_ext>34200</phone_ext>
    <email>liesa.weiler@meduniwien.ac.at</email>
  </overall_contact>
  <location>
    <facility>
      <name>Kepler Universitätsklinikum</name>
      <address>
        <city>Linz</city>
        <state>Oberösterreich</state>
        <zip>4021</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alina Kollmann, Mag.</last_name>
      <phone>+43576808425209</phone>
      <email>alina.kollmann@meduniwien.ac.at</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Rehabilitationszentrum St. Veit im Pongau</name>
      <address>
        <city>St. Veit</city>
        <state>Salzburg</state>
        <zip>5621</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Martina Geihseder-Zach, Mag.</last_name>
      <phone>+436415</phone>
      <phone_ext>50300</phone_ext>
      <email>martina.geihseder-zach@reha-stveit.at</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Medical University Graz</name>
      <address>
        <city>Graz</city>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Karin Wiegele, Mag.</last_name>
      <phone>+4331638584513</phone>
      <email>karin.wiegele@klinikum-graz.at</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Uniklinikum Salzburg</name>
      <address>
        <city>Salzburg</city>
        <zip>5020</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stefanie Essl, Mag.</last_name>
      <phone>+4357255</phone>
      <phone_ext>55722</phone_ext>
      <email>s.essl@salk.at</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Medical University of Vienna</name>
      <address>
        <city>Vienna</city>
        <zip>1090</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Liesa Weiler-Wichtl, Dr.</last_name>
      <phone>+43140400</phone>
      <phone_ext>34200</phone_ext>
      <email>liesa.weiler@meduniwien.ac.at</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>St. Anna Kinderspital</name>
      <address>
        <city>Vienna</city>
        <zip>1090</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stephanie Kirschner, Mag.</last_name>
      <phone>+43140170</phone>
      <phone_ext>26859336</phone_ext>
      <email>stephanie.kirschner@stanna.at</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Cnopfsche Kinderklinik</name>
      <address>
        <city>Nürnberg</city>
        <state>Bayern</state>
        <zip>90419</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Susan Kertscher</last_name>
      <phone>+4991133404812</phone>
      <email>susan.kertscher@diakoneo.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Frankfurt am Main</name>
      <address>
        <city>Frankfurt am Main</city>
        <state>Hessen</state>
        <zip>60590</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Medizinische Hochschule Hannover</name>
      <address>
        <city>Hannover</city>
        <state>Niedersachsen</state>
        <zip>30625</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anne Paduch, MSc.</last_name>
      <phone>+49511532 9063</phone>
      <email>Paduch.Anne@mh-hannover.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Essen</name>
      <address>
        <city>Essen</city>
        <state>Nordrhein-Westfalen</state>
        <zip>45147</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Andreas Wiener, Dr.</last_name>
      <phone>+49 201 723 6600</phone>
      <email>andreas.wiener@uk-essen.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Münster</name>
      <address>
        <city>Münster</city>
        <state>Nordrhein-Westfalen</state>
        <zip>48149</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nicole Salzmann, Dipl.-Psych.</last_name>
      <phone>+492518343402</phone>
      <email>Nicole.Salzmann@ukmuenster.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum des Saarlandes</name>
      <address>
        <city>Homburg</city>
        <state>Saarland</state>
        <zip>66421</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Iris Lein-Köhler, Dipl.-Psych.</last_name>
      <phone>+4968411628406</phone>
      <email>iris.lein-koehler@uks.eu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Leipzig</name>
      <address>
        <city>Leipzig</city>
        <state>Sachsen</state>
        <zip>04103</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Florian Schepper, Dr.</last_name>
      <phone>+491636334776</phone>
      <email>florian.schepper@medizin.uni-leipzig.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Klinik Bad Oexen</name>
      <address>
        <city>Bad Oeynhausen</city>
        <zip>32549</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kirsten Neumann</last_name>
      <phone>+49 / (0)5731 / 537-8879</phone>
      <email>Neumann@badoexen.de</email>
    </contact>
    <contact_backup>
      <last_name>Michael Büser</last_name>
      <email>bueser@badoexen.de</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Charité - Universitätsmedizin Berlin</name>
      <address>
        <city>Berlin</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tobias Schellenberg</last_name>
      <phone>004930450566276</phone>
      <email>tobias.schellenberg@charite.de</email>
    </contact>
    <contact_backup>
      <last_name>Grace O'Malley</last_name>
      <email>grace.omalley@charite.de</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Luca-Dethlefsen-Hilfe e.V.</name>
      <address>
        <city>Bielefeld</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christiane Faist-Schweika, Dipl. Psych.</last_name>
      <phone>0521- 772 79254</phone>
      <email>Christiane.Faist-Schweika@evkb.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Uniklinik Köln</name>
      <address>
        <city>Cologne</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Hiltrud Gauf, Dipl.-Kunsttherapeutin</last_name>
      <phone>+49 2214786832</phone>
      <email>hiltrud.gauf@uk-koeln.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Carl Gustav Carus Dresden</name>
      <address>
        <city>Dresden</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mihaela Budich, Dipl. Psych</last_name>
      <email>Mihaela.Budich@uniklinikum-dresden.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Erlangen</name>
      <address>
        <city>Erlangen</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Leonie Roderus</last_name>
      <phone>00499913121930</phone>
      <email>leonie.roderus@kinder-erlangen.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Hamburg-Eppendorf</name>
      <address>
        <city>Hamburg</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maike Reddig</last_name>
      <phone>+004940741055434</phone>
      <email>m.reddig@uke.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Staedtisches Klinikum Karlsruhe</name>
      <address>
        <city>Karlsruhe</city>
        <zip>76133</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sonja Görgen</last_name>
      <email>Sonja.Goergen@klinikum-karlsruhe.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Schleswig-Holstein</name>
      <address>
        <city>Kiel</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Heike Wienands</last_name>
      <phone>0431 500 20 286</phone>
      <email>heike.wienands@uksh.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Mannheim</name>
      <address>
        <city>Mannheim</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ulrike Just, Dipl. Psych</last_name>
      <phone>+49 (621) 383-3364</phone>
      <email>ulrike.just@umm.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Regensburg</name>
      <address>
        <city>Regensburg</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Irmgard Scherübl</last_name>
      <phone>+49 941 / 944 12022</phone>
      <email>irmgard1.scheruebl@klinik.uni-regensburg.de</email>
    </contact>
    <contact_backup>
      <last_name>Elisabeth Kühn-Wolff</last_name>
      <email>Elisabeth.Kuehn-Wolff@klinik.uni-regensburg.de</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Tübingen</name>
      <address>
        <city>Tübingen</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Natasha Krüger</last_name>
      <phone>0049070712983377</phone>
      <email>Natasha.Krueger@med.uni-tuebingen.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Würzburg</name>
      <address>
        <city>Würzburg</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lisa Schubert</last_name>
      <email>schubert_l@ukw.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ospedale di Bolzano</name>
      <address>
        <city>Bolzano</city>
        <state>Trentino-Alto Adige</state>
        <zip>39100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Barbara Schönthaler</last_name>
      <phone>+39471909796</phone>
      <email>barbara.schönthaler@sabes.it</email>
    </contact>
    <contact_backup>
      <last_name>Martina Kosta</last_name>
      <email>martina.kosta@rolmail.net</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Inselspital, Universitätsspital Bern</name>
      <address>
        <city>Bern</city>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Andrea Kurzo</last_name>
      <phone>+41 (0) 31 632 94 64</phone>
      <email>andrea.kurzo@insel.ch</email>
    </contact>
    <contact_backup>
      <last_name>Dorothea Schönenberger-Loppacher</last_name>
      <email>dorothee.schoenenberger@insel.ch</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Austria</country>
    <country>Germany</country>
    <country>Italy</country>
    <country>Switzerland</country>
  </location_countries>
  <reference>
    <citation>Kazak AE, Abrams AN, Banks J, Christofferson J, DiDonato S, Grootenhuis MA, Kabour M, Madan-Swain A, Patel SK, Zadeh S, Kupst MJ. Psychosocial Assessment as a Standard of Care in Pediatric Cancer. Pediatr Blood Cancer. 2015 Dec;62 Suppl 5:S426-59. doi: 10.1002/pbc.25730.</citation>
    <PMID>26700916</PMID>
  </reference>
  <reference>
    <citation>Scialla MA, Canter KS, Chen FF, Kolb EA, Sandler E, Wiener L, Kazak AE. Delivery of care consistent with the psychosocial standards in pediatric cancer: Current practices in the United States. Pediatr Blood Cancer. 2018 Mar;65(3):10.1002/pbc.26869. doi: 10.1002/pbc.26869. Epub 2017 Oct 28.</citation>
    <PMID>29080381</PMID>
  </reference>
  <reference>
    <citation>Baxter S, Johnson M, Chambers D, Sutton A, Goyder E, Booth A. The effects of integrated care: a systematic review of UK and international evidence. BMC Health Serv Res. 2018 May 10;18(1):350. doi: 10.1186/s12913-018-3161-3.</citation>
    <PMID>29747651</PMID>
  </reference>
  <reference>
    <citation>Schurman JV, Gayes LA, Slosky L, Hunter ME, Pino FA. Publishing quality improvement work in Clinical Practice in Pediatric Psychology: The &quot;why&quot; and &quot;how to&quot;. Clinical Practice in Pediatric Psychology. 2015 Mar; 3(1):80.</citation>
  </reference>
  <reference>
    <citation>Schreiber-Gollwitzer BM, Schroder HM, Griessmeier B, Labouvie H, Lilienthal S; PSAPOH. [Quantitative and qualitative evaluation of psychosocial care for patients in pediatric oncology and hematology--a multicenter study on behalf of the PSAPOH]. Klin Padiatr. 2003 May-Jun;215(3):171-6. doi: 10.1055/s-2003-39377. German.</citation>
    <PMID>12778358</PMID>
  </reference>
  <reference>
    <citation>Stuber ML, Meeske KA, Krull KR, Leisenring W, Stratton K, Kazak AE, Huber M, Zebrack B, Uijtdehaage SH, Mertens AC, Robison LL, Zeltzer LK. Prevalence and predictors of posttraumatic stress disorder in adult survivors of childhood cancer. Pediatrics. 2010 May;125(5):e1124-34. doi: 10.1542/peds.2009-2308.</citation>
    <PMID>20435702</PMID>
  </reference>
  <reference>
    <citation>Koch U, Mehnert A, Harter M. [Chronic somatic disorders and psychological comorbidity]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2011 Jan;54(1):1-3. doi: 10.1007/s00103-010-1196-7. No abstract available. German.</citation>
    <PMID>21246321</PMID>
  </reference>
  <verification_date>January 2023</verification_date>
  <study_first_submitted>June 23, 2020</study_first_submitted>
  <study_first_submitted_qc>July 13, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">July 17, 2020</study_first_posted>
  <last_update_submitted>January 24, 2023</last_update_submitted>
  <last_update_submitted_qc>January 24, 2023</last_update_submitted_qc>
  <last_update_posted type="Actual">January 25, 2023</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Medical University of Vienna</investigator_affiliation>
    <investigator_full_name>Dr. Liesa J. Weiler-Wichtl</investigator_full_name>
    <investigator_title>Project Coordinator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neuroblastoma</mesh_term>
    <mesh_term>Neurofibromatoses</mesh_term>
    <mesh_term>Neurofibromatosis 1</mesh_term>
    <mesh_term>Neurofibroma</mesh_term>
    <mesh_term>Hematologic Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>


download date: ClinicalTrials.gov processed this data on September 20, 2023
link text: Link to the current ClinicalTrials.gov record.
url: https://clinicaltrials.gov/ct2/show/NCT04474678
org study id: 1564/2017
nct id: NCT04474678
lead sponsor: 
collaborator: 
collaborator: 
collaborator: 
collaborator: 
collaborator: 
collaborator: 
collaborator: 
collaborator: 
collaborator: 
collaborator: 
collaborator: 
collaborator: 
collaborator: 
collaborator: 
collaborator: 
collaborator: 
collaborator: 
collaborator: 
collaborator: 
collaborator: 
collaborator: 
collaborator: 
collaborator: 
collaborator: 
collaborator: 
collaborator: 
collaborator: 
has dmc: No
is fda regulated drug: No
is fda regulated device: No
In this study, the main goal is to implement and evaluate a novel, evidence-based
      psycho-educative program for children in oncological care. Patients are provided with
      booklets tailored to each specific stage of their treatment. Among other factors, children's
      emotional well-being is evaluated as well as feasibility. The study is carried out at
      multiple sites across Austria, Germany and Italy/South Tirol.
It is well documented that the prevalence of mental disorders in childhood cancer survivors
      is twice to quadruple compared to healthy controls. Effects range from impaired emotional
      balance, fear of recidivisms, helplessness, depression to post traumatic stress disorder.

      As a basis for interventions to preventively address these issues and moreover, to achieve
      defined psychosocial goals in the field of paediatric oncology, guidelines and standards
      systematically describe stressors and resources in particularly challenging situations.
      Nevertheless, despite these guidelines, actual care is quite heterogenous due to differences
      in setting, provision and profession. Studies show that integrated models of psychosocial
      care yield better outcomes. Integrated care systems can enhance patient satisfaction,
      increase perceived quality of care, and enable access to services and reduce service costs.
      Highly complex, system-wide interventions such as models of integrated care represent
      considerable challenges for operationalisation of relevant factors and evaluation of whole
      processes compared to single interventions (e.g. relaxation techniques). Quality improvement
      (QI) is an iterative process designed to make controlled changes within the health care
      delivery system to provide patients with high-quality care that meets both their expectations
      and needs. In terms of quality assurance, this QI Project aims to operationalize
      recommendations of the S3 guideline for psychosocial care which results in a combined
      process- and patient-oriented intervention and evaluation tool - bridging the gap between
      standards/evidence and clinical practice.

      The "Onco-Mini-Version" of "My Logbook - I know my way around" already comprises a
      Starter-Kit and 8 booklets, which cover at least one main issue of every treatment phase:
      initial contact, medical assessment (MRI), supportive therapy (chemotherapy, radio therapy),
      rehabilitation and after-care. All interventions are carried out by a clinical psychologist
      or psychosocial staff specialized in pediatric psychooncology and are understood as part of
      an integrated care system. Every booklet provides practical materials with enhanced
      stimulating elements to encourage the child to explore actively. The booklets are structured
      in two face-to-face sessions covering psychoeducational, activity & practice and reflective
      aspects.

      The core of this QI project is a multilevel and interdisciplinary approach characterized by
      iterative processes. PDSA (Plan, Do, Study, Act) cycles were applied in all steps of
      conceptualization and implementation of this project. It aims to systematically improve
      psychosocial care of pediatric cancer patients through being implemented in a large number of
      hospitals in the German-speaking world. The proposed multicenter pilot phase promotes
      emotional well-being and level of information of the child during treatment through transfer
      of knowledge and coping skills. Moreover, it addresses feasibility of the tool but also the
      impact of medical procedures on feasibility. In the long term, the program is intended to
      help attenuate psychological late effects of oncological conditions and their treatments.
allocation: N/A
intervention model: Single Group Assignment
primary purpose: Treatment
masking: None (Open Label)
measure: Emotional well-being, T1
time frame: Based on the medical therapy protocol, after medical consultation, prior to first session of the special issue (booklet) - through study completion or end of medical treatment, an average of 1 year
description: Patients' emotional well-being is evaluated using a visual array of emotional displays. Patients can choose three emotions that describe their current situation best. For analysis, emotions are categorized into positive, neutral, and negative emotions. Emotional well-being is evaluated longitudinally over multiple points of time. The diagnostic tool was developed in-house, publication is pending.
measure: Emotional well-being, T2
time frame: Post to first session of the special issue (booklet) - through study completion or end of medical treatment, an average of 1 year
description: Patients' emotional well-being is evaluated using a visual array of emotional displays. Patients can choose three emotions that describe their current situation best. For analysis, emotions are categorized into positive, neutral, and negative emotions. Emotional well-being is evaluated longitudinally over multiple points of time. The diagnostic tool was developed in-house, publication is pending.
measure: Emotional well-being, T3
time frame: During, but before completion of treatment; prior to second session of the special issue (booklet) - through study completion or end of medical treatment, an average of 1 year
description: Patients' emotional well-being is evaluated using a visual array of emotional displays. Patients can choose three emotions that describe their current situation best. For analysis, emotions are categorized into positive, neutral, and negative emotions. Emotional well-being is evaluated longitudinally over multiple points of time. The diagnostic tool was developed in-house, publication is pending.
measure: Emotional well-being, T4
time frame: During, post to second session of the special issue (booklet) - through study completion or end of medical treatment, an average of 1 year
description: Patients' emotional well-being is evaluated using a visual array of emotional displays. Patients can choose three emotions that describe their current situation best. For analysis, emotions are categorized into positive, neutral, and negative emotions. Emotional well-being is evaluated longitudinally over multiple points of time. The diagnostic tool was developed in-house, publication is pending.
measure: Emotional well-being, T5
time frame: During, but before completion of treatment - through study completion or end of medical treatment, an average of 1 year
description: Patients' emotional well-being is evaluated using a visual array of emotional displays. Patients can choose three emotions that describe their current situation best. For analysis, emotions are categorized into positive, neutral, and negative emotions. Emotional well-being is evaluated longitudinally over multiple points of time. The diagnostic tool was developed in-house, publication is pending.
measure: Knowledgeability, T1
time frame: Based on the medical therapy protocol, after medical consultation, prior to first session of the special issue (booklet) - through study completion or end of medical treatment, an average of 1 year
description: Patients are asked to rate their own knowledgeability regarding treatment, illness and hospital environment on a five-point scale ranging from "beginner" to "expert". Knowledgeability is evaluated longitudinally over multiple points of time. The diagnostic tool was developed in-house.
measure: Knowledgeability, T2
time frame: Post to first session of the special issue (booklet) - through study completion or end of medical treatment, an average of 1 year
description: Patients are asked to rate their own knowledgeability regarding treatment, illness and hospital environment on a five-point scale ranging from "beginner" to "expert". Knowledgeability is evaluated longitudinally over multiple points of time. The diagnostic tool was developed in-house.
measure: Knowledgeability, T3
time frame: During, but before completion of treatment; prior to second session of the special issue (booklet) - through study completion or end of medical treatment, an average of 1 year
description: Patients are asked to rate their own knowledgeability regarding treatment, illness and hospital environment on a five-point scale ranging from "beginner" to "expert". Knowledgeability is evaluated longitudinally over multiple points of time. The diagnostic tool was developed in-house.
measure: Knowledgeability, T4
time frame: During, post to second session of the special issue (booklet) - through study completion or end of medical treatment, an average of 1 year
description: Patients are asked to rate their own knowledgeability regarding treatment, illness and hospital environment on a five-point scale ranging from "beginner" to "expert". Knowledgeability is evaluated longitudinally over multiple points of time. The diagnostic tool was developed in-house.
measure: Knowledgeability, T5
time frame: During, but before completion of treatment - through study completion or end of medical treatment, an average of 1 year
description: Patients are asked to rate their own knowledgeability regarding treatment, illness and hospital environment on a five-point scale ranging from "beginner" to "expert". Knowledgeability is evaluated longitudinally over multiple points of time. The diagnostic tool was developed in-house.
measure: Feasibility of program
time frame: Feasibility of program is evaluated following the second session which on average takes place one to six months after start of the treatment of the special issue (booklet). - through study completion or end of medical treatment, an average of 1 year
description: Rating of feasibility of the program by medical staff
measure: Intelligence test
time frame: During the first two months from diagnosis or start of psychosocial treatment - up to three Months
description: Patients are administered a standardized intelligence test, dependent on their age, e.g.
Wechsler Intelligence Scale for Children IV WISC-IV, Petermann & Petermann, 2014 or other comparable methods due to clinical standards
measure: Strengths and Difficulties Questionnaire (SDQ; Goodman, 1999)
time frame: During the first two months from diagnosis or start of psychosocial treatment - up to three Months
description: The Strengths and Difficulties Questionnaire (SDQ) is a brief behavioural screening questionnaire about 3-16 year olds.
measure: KINDLR (Ravens-Sieberer & Bullinger, 2000)
time frame: During the first two months from diagnosis or start of psychosocial treatment - up to three Months
description: The KINDLR is a standardized questionnaire for the assessment of quality of life in children and adolescents.
measure: Questionnaire on Health Competence in Children and Adolescents, (Weiler, Fohn, Pletschko, Schwarzinger, & Leiss, 2017)
time frame: During the first two months from diagnosis or start of psychosocial treatment - up to three Months
description: Questionnaire for the assessment of health competence in children and adolescents
measure: Medical information
time frame: Within the first week of treatment - up to three Months
description: Diagnosis, date of diagnosis, pre-existing conditions, secondary conditions, form of treatment/therapy, psychiatric diagnoses, neurological status
measure: Demographic data
time frame: During the first two months from diagnosis or start of psychosocial treatment - up to three Months
description: Age of patient, sex, parents' education, parents' profession, school form, mother language of patient
arm group label: All Patients
arm group type: Other
description: Since this is a single-group study, all patients are within the same arm
intervention type: Other
intervention name: "My Logbook! - I know my way around!"
description: Special issues/booklets of "My Logbook - I know my way around!" - Every booklet is based on evidence-based interventions. It illustrates psychosocial and interdisciplinary processes in a standardized way, resulting in a practical guide ("My Logbook") to accompany the child throughout all stages of oncological treatment.
arm group label: All Patients
criteria: 
gender: All
minimum age: 6 Years
maximum age: 14 Years
healthy volunteers: No
last name: Liesa Weiler-Wichtl, Dr.
phone: +43140400
phone ext: 34200
email: liesa.weiler@meduniwien.ac.at
facility: 
status: Recruiting
contact: 
facility: 
status: Recruiting
contact: 
facility: 
status: Recruiting
contact: 
facility: 
status: Recruiting
contact: 
facility: 
status: Recruiting
contact: 
facility: 
status: Recruiting
contact: 
facility: 
status: Recruiting
contact: 
facility: 
status: Active, not recruiting
facility: 
status: Recruiting
contact: 
facility: 
status: Recruiting
contact: 
facility: 
status: Recruiting
contact: 
facility: 
status: Recruiting
contact: 
facility: 
status: Recruiting
contact: 
facility: 
status: Recruiting
contact: 
contact backup: 
facility: 
status: Recruiting
contact: 
contact backup: 
facility: 
status: Recruiting
contact: 
facility: 
status: Not yet recruiting
contact: 
facility: 
status: Recruiting
contact: 
facility: 
status: Recruiting
contact: 
facility: 
status: Recruiting
contact: 
facility: 
status: Recruiting
contact: 
facility: 
status: Recruiting
contact: 
facility: 
status: Recruiting
contact: 
facility: 
status: Recruiting
contact: 
contact backup: 
facility: 
status: Recruiting
contact: 
facility: 
status: Recruiting
contact: 
facility: 
status: Recruiting
contact: 
contact backup: 
facility: 
status: Recruiting
contact: 
contact backup: 
country: Austria
country: Germany
country: Italy
country: Switzerland
citation: Kazak AE, Abrams AN, Banks J, Christofferson J, DiDonato S, Grootenhuis MA, Kabour M, Madan-Swain A, Patel SK, Zadeh S, Kupst MJ. Psychosocial Assessment as a Standard of Care in Pediatric Cancer. Pediatr Blood Cancer. 2015 Dec;62 Suppl 5:S426-59. doi: 10.1002/pbc.25730.
PMID: 26700916
citation: Scialla MA, Canter KS, Chen FF, Kolb EA, Sandler E, Wiener L, Kazak AE. Delivery of care consistent with the psychosocial standards in pediatric cancer: Current practices in the United States. Pediatr Blood Cancer. 2018 Mar;65(3):10.1002/pbc.26869. doi: 10.1002/pbc.26869. Epub 2017 Oct 28.
PMID: 29080381
citation: Baxter S, Johnson M, Chambers D, Sutton A, Goyder E, Booth A. The effects of integrated care: a systematic review of UK and international evidence. BMC Health Serv Res. 2018 May 10;18(1):350. doi: 10.1186/s12913-018-3161-3.
PMID: 29747651
citation: Schurman JV, Gayes LA, Slosky L, Hunter ME, Pino FA. Publishing quality improvement work in Clinical Practice in Pediatric Psychology: The "why" and "how to". Clinical Practice in Pediatric Psychology. 2015 Mar; 3(1):80.
citation: Schreiber-Gollwitzer BM, Schroder HM, Griessmeier B, Labouvie H, Lilienthal S; PSAPOH. [Quantitative and qualitative evaluation of psychosocial care for patients in pediatric oncology and hematology--a multicenter study on behalf of the PSAPOH]. Klin Padiatr. 2003 May-Jun;215(3):171-6. doi: 10.1055/s-2003-39377. German.
PMID: 12778358
citation: Stuber ML, Meeske KA, Krull KR, Leisenring W, Stratton K, Kazak AE, Huber M, Zebrack B, Uijtdehaage SH, Mertens AC, Robison LL, Zeltzer LK. Prevalence and predictors of posttraumatic stress disorder in adult survivors of childhood cancer. Pediatrics. 2010 May;125(5):e1124-34. doi: 10.1542/peds.2009-2308.
PMID: 20435702
citation: Koch U, Mehnert A, Harter M. [Chronic somatic disorders and psychological comorbidity]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2011 Jan;54(1):1-3. doi: 10.1007/s00103-010-1196-7. No abstract available. German.
PMID: 21246321
responsible party type: Principal Investigator
investigator affiliation: Medical University of Vienna
investigator full name: Dr. Liesa J. Weiler-Wichtl
investigator title: Project Coordinator
mesh term: Neuroblastoma
mesh term: Neurofibromatoses
mesh term: Neurofibromatosis 1
mesh term: Neurofibroma
mesh term: Hematologic Diseases
sharing ipd: No